These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2850143)

  • 1. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease.
    Brownlee M; Cerami A; Vlassara H
    Diabetes Metab Rev; 1988 Aug; 4(5):437-51. PubMed ID: 2850143
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonenzymatic glycation: a central mechanism in diabetic microvasculopathy?
    Cohen MP
    J Diabet Complications; 1988; 2(4):214-7. PubMed ID: 2976766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein.
    Brownlee M; Vlassara H; Cerami A
    Diabetes; 1985 Sep; 34(9):938-41. PubMed ID: 4029512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes, advanced glycation endproducts and vascular disease.
    Wautier JL; Guillausseau PJ
    Vasc Med; 1998; 3(2):131-7. PubMed ID: 9796076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathophysiologic aspects of diabetic angiopathy].
    Wautier JL; Wautier MP
    Diabetes Metab; 1999 Jun; 25 Suppl 3():21-6. PubMed ID: 10421989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease.
    Asleh R; Marsh S; Shilkrut M; Binah O; Guetta J; Lejbkowicz F; Enav B; Shehadeh N; Kanter Y; Lache O; Cohen O; Levy NS; Levy AP
    Circ Res; 2003 Jun; 92(11):1193-200. PubMed ID: 12750308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein browning and diabetic complications.
    Jones AF; Jennings PE; Wakefield A; Winkles JW; Lunec J; Barnett AH
    Lancet; 1986 Aug; 2(8504):459. PubMed ID: 2874441
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic factors in the genesis of diabetic microangiopathy.
    Parving HH; Viberti GC; Keen H; Christiansen JS; Lassen NA
    Metabolism; 1983 Sep; 32(9):943-9. PubMed ID: 6350816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetic microangiopathy--pathogenesis].
    Hotta N; Sakamoto N
    Nihon Rinsho; 1991 Feb; 49 Suppl():25-33. PubMed ID: 1903463
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic vascular disease: it's all the RAGE.
    Hudson BI; Wendt T; Bucciarelli LG; Rong LL; Naka Y; Yan SF; Schmidt AM
    Antioxid Redox Signal; 2005; 7(11-12):1588-600. PubMed ID: 16356122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycation, receptor-mediated cell activation and vascular complications of diabetes.
    Thornalley PJ
    Diab Vasc Dis Res; 2004 May; 1(1):21-2. PubMed ID: 16305051
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus.
    Nakamura Y; Horii Y; Nishino T; Shiiki H; Sakaguchi Y; Kagoshima T; Dohi K; Makita Z; Vlassara H; Bucala R
    Am J Pathol; 1993 Dec; 143(6):1649-56. PubMed ID: 8256853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Collagen metabolism in diabetic microangiopathies].
    Danilov IP; Okorokov AN; Bobkov VIa
    Klin Med (Mosk); 1980 Feb; 58(2):58-62. PubMed ID: 7366160
    [No Abstract]   [Full Text] [Related]  

  • 14. Progressive glycosylation of albumin and its effect on the binding of homocysteine may be a key step in the pathogenesis of vascular damage in diabetes mellitus.
    Mathai M; Radford SE; Holland P
    Med Hypotheses; 2007; 69(1):166-72. PubMed ID: 17224246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aminoguanidine].
    Kawano M; Kawakami M
    Nihon Rinsho; 1997 Nov; 55 Suppl():221-4. PubMed ID: 9434471
    [No Abstract]   [Full Text] [Related]  

  • 16. Food-advanced glycation end products aggravate the diabetic vascular complications via modulating the AGEs/RAGE pathway.
    Lv X; Lv GH; Dai GY; Sun HM; Xu HQ
    Chin J Nat Med; 2016 Nov; 14(11):844-855. PubMed ID: 27914528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis and prevention diabetes mellitus vascular complications].
    Balabolkin MI; Kreminskaia VM
    Ter Arkh; 1999; 71(10):5-12. PubMed ID: 10612165
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
    Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Vlad D; Popescu R; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Jianu DC
    J Diabetes Complications; 2015 Mar; 29(2):230-7. PubMed ID: 25511877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Lipoproteins, glycoxidation and diabetic angiopathy'.
    Jenkins AJ; Best JD; Klein RL; Lyons TJ
    Diabetes Metab Res Rev; 2004; 20(5):349-68. PubMed ID: 15343582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis.
    Makita Z; Yanagisawa K; Kuwajima S; Bucala R; Vlassara H; Koike T
    Nephrol Dial Transplant; 1996; 11 Suppl 5():31-3. PubMed ID: 9044304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.